相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry
Patrick Maeder et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T.b. brucei hitcompound with improved pharmacokinetic properties
Cyril Fersing et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity
Cyril Fersing et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Fexinidazole for the treatment of human African trypanosomiasis
A. H. Fairlamb
DRUGS OF TODAY (2019)
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a] pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases
Cyril Fersing et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Neglected tropical diseases: progress towards addressing the chronic pandemic
David H. Molyneux et al.
LANCET (2017)
Eaton's reagent-mediated metal-free and efficient synthesis of NH-sulfoximines
Jianping Wang et al.
TETRAHEDRON LETTERS (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Mechanistic investigation of the NH-sulfoximination of sulfide. Evidence for λ6-sulfanenitrile intermediates
Jean-Francois Lohier et al.
CHEMICAL COMMUNICATIONS (2017)
Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
Neil R. H. Stone et al.
DRUGS (2016)
Hit and lead criteria in drug discovery for infectious diseases of the developing world
Kei Katsuno et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
An update on pharmacotherapy for leishmaniasis
Shyam Sundar et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment
Cedric Lecoutey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects
Stephen Patterson et al.
TRENDS IN PARASITOLOGY (2014)
Targeting the human parasite Leishmania donovani: Discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series
Caroline Castera-Ducros et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Antimalarial pharmacology and therapeutics of atovaquone
Gemma L. Nixon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation
Belinda S. Hall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Thomas P. C. Dorlo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial
Ahmed Musa et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites
Belinda S. Hall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Amphotericin B nephrotoxicity
G Deray
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
分享论文
